| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0140-6736(77)92114-6 |
| P953 | full work available at URL | https://api.elsevier.com/content/article/PII:S0140673677921146?httpAccept=text/plain |
| https://api.elsevier.com/content/article/PII:S0140673677921146?httpAccept=text/xml | ||
| P698 | PubMed publication ID | 66473 |
| P50 | author | Michele Goodhardt | Q57016412 |
| C R Hiley | Q67018018 | ||
| P2093 | author name string | P. White | |
| J. P. Keet | |||
| D. M. Bowen | |||
| L. H. Carrasco | |||
| I. E. Williams | |||
| P2860 | cites work | Alterations of brain neurotransmitter receptor binding in Huntington's chorea | Q31152135 |
| Editorial: The prevalence and malignancy of Alzheimer disease. A major killer | Q34178758 | ||
| Cerebral blood flow in dementia | Q34518886 | ||
| Muscarinic cholinergic binding in rat brain | Q37442793 | ||
| Neurotransmitter-related enzymes and indices of hypoxia in senile dementia and other abiotrophies | Q39125647 | ||
| Decreased muscarinic receptor concentration in post-mortem brain in Huntington's chorea | Q45302987 | ||
| Necropsy evidence of central cholinergic deficits in senile dementia | Q48319379 | ||
| Selective loss of central cholinergic neurons in Alzheimer's disease | Q48342983 | ||
| Measurement and activation of choline acetyltransferase | Q48461733 | ||
| Human memory and the cholinergic system. A relationship to aging? | Q48584703 | ||
| The cerebral cortex in presenile dementia. A quantitative analysis | Q48695913 | ||
| P433 | issue | 8013 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | muscarinic acetylcholine receptor family | Q410959 |
| P304 | page(s) | 668-671 | |
| P577 | publication date | 1977-03-01 | |
| 1977-03-26 | |||
| P1433 | published in | The Lancet | Q939416 |
| P1476 | title | Neocortical cholinergic neurons in elderly people | |
| P478 | volume | 1 |
| Q39451637 | A Review of Biomarkers for Neurodegenerative Disease: Will They Swing Us Across the Valley? |
| Q42150542 | A comparison of changes in the nucleus basalis and locus caeruleus in Alzheimer's disease |
| Q33621285 | A double-blind, placebo controlled trial of high-dose lecithin in Alzheimer's disease |
| Q48214186 | A long-term follow-up study of cerebrospinal fluid acetylcholinesterase in delirium |
| Q36078030 | A meta-analysis of the effects of aging on motor cortex neurophysiology assessed by transcranial magnetic stimulation |
| Q48712776 | A post-mortem comparison of the cortical cholinergic system in Alzheimer's disease and Pick's disease |
| Q35844609 | A systematic review of neurotransmitter deficits and treatments in frontotemporal dementia |
| Q39525178 | Accelerated ageing or selective neuronal loss as an important cause of dementia? |
| Q36302845 | Acetylcholinesterase inhibitors for the treatment of dementia in Alzheimer's disease: do we need new inhibitors? |
| Q34011160 | Advances in the pharmacotherapy of Alzheimer's disease |
| Q33739635 | Advances in understanding the mechanisms and management of persistent pain in older adults |
| Q72531341 | Affective disorders in the aged |
| Q53196490 | Age and Alzheimer disease |
| Q40084655 | Age-related behavioral and neurobiological changes: a review with an emphasis on memory |
| Q30418974 | Age-related changes in signal transduction. Implications for neuronal transmission and potential for drug intervention |
| Q49124075 | Age-related decline in central cholinergic function demonstrated with scopolamine |
| Q66696365 | Aluminium and Alzheimer's disease |
| Q34717505 | Alzheimer disease: Evidence for selective loss of cholinergic neurons in the nucleus basalis |
| Q39389276 | Alzheimer's disease and senile dementia: biochemical characteristics and aspects of treatment |
| Q48679838 | Alzheimer's presenile dementia, senile dementia of Alzheimer type and Down's syndrome in middle age form an age related continuum of pathological changes |
| Q53196317 | Alzheimer-like cholinergic deficiency in Down syndrome |
| Q52197305 | Ameliorating effects of SDZ ENA 713 on age-associated decreases in learning performance and brain choline acetyltransferase activity in rats. |
| Q48952014 | Angiotensin Converting Enzyme in Alzheimer's Disease: Increased Activity in Caudate Nucleus and Cortical Areas |
| Q31911220 | Assessment of muscarinic receptor concentrations in aging and Alzheimer disease with [11C]NMPB and PET. |
| Q48654715 | Autoradiographic distribution of M1, M2, M3, and M4 muscarinic receptor subtypes in Alzheimer's disease |
| Q41123446 | Autotransplantation of peripheral cholinergic neurons into the brains of Alzheimer model rats |
| Q56961136 | Basal forebrain cholinergic system volume is associated with general cognitive ability in the elderly |
| Q42453090 | Biochemical Assessment of Serotonergic and Cholinergic Dysfunction and Cerebral Atrophy in Alzheimer's Disease |
| Q42446821 | Biochemical evidence of selective nerve cell changes in the normal ageing human and rat brain. |
| Q40264745 | Biochemistry of Alzheimer's dementia |
| Q34982070 | Biochemistry of Dementias |
| Q69879034 | Brain dopamine D-2 receptors in senile dementia |
| Q48713477 | Catecholamines and cholinergic enzymes in pre-senile and senile Alzheimer-type dementia and down's syndrome |
| Q41084079 | Central Anticholinergic Hypersensitivity in Aging |
| Q52050063 | Cerebrospinal fluid acetylcholinesterase in patients with dementia associated with schizophrenia or chronic alcoholism. |
| Q48176243 | Changes in brain cholinesterases in senile dementia of Alzheimer type |
| Q40089419 | Changes in the mechanisms of hormone and neurotransmitter action during aging: Current status of the role of receptor and post-receptor alterations. A review |
| Q48270075 | Characterization of L-[3H]nicotine binding in human cerebral cortex: comparison between Alzheimer's disease and the normal |
| Q40178455 | Choline acetyltransferase: Purification and immunohistochemical localization |
| Q71012905 | Choline chloride fails to improve cognition in Alzheimer's disease |
| Q48257631 | Choline in Alzheimer's disease |
| Q71223306 | Choline, acetylcholine and dementia |
| Q39460975 | Cholinergic dysfunction in Alzheimer disease: cause or effect? |
| Q42473091 | Cholinergic imaging in corticobasal syndrome, progressive supranuclear palsy and frontotemporal dementia |
| Q49158975 | Cholinergic receptors in human hippocampus-- regional distribution and variance with age |
| Q69028580 | Cholinergic topography in Alzheimer brains: a comparison with changes in the monoaminergic profile |
| Q39780851 | Cholinergic underactivity in human memory disorders |
| Q66698116 | Cholinesterase inhibition in treatment of Alzheimer's dementia |
| Q38596419 | Chronic oral physostigmine without lecithin improves memory in Alzheimer's disease |
| Q43492625 | Clinical effects of choline in Alzheimer senile dementia |
| Q66698016 | Clinical effects of choline in Alzheimer's disease |
| Q35164747 | Clinically tested drugs for Alzheimer's disease |
| Q53196480 | Coenzyme a-acetylating enzymes in Alzheimer's disease: Possible cholinergic ‘compartment’ of pyruvate dehydrogenase |
| Q50869517 | Correlation of cholinergic abnormalities with senile plaques and mental test scores in senile dementia. |
| Q48860487 | Cortical muscarinic receptor subtypes and Alzheimer's disease |
| Q39173624 | Critical review of clinical trials in senile dementia--II. |
| Q48624756 | Decreased cortical glucose utilization after ibotenate lesion of the rat ventromedial globus pallidus |
| Q40093538 | Dementia in the elderly: biochemical aspects. |
| Q39527834 | Depression in the elderly: the role of the primary care physician in management |
| Q41440662 | Dexamethasone suppression test and response to antidepressant therapy in psychogeriatric patients |
| Q68546941 | Diagnosis of dementia in cancer patients. Cognitive impairment in these patients can go unrecognized |
| Q97542597 | Diclofenac reduces the risk of Alzheimer's disease: a pilot analysis of NSAIDs in two US veteran populations |
| Q39277351 | Dietary Influences on the Synthesis of Neurotransmitters in the Brain |
| Q52013778 | Differential cholinergic regulation in Alzheimer's patients compared to controls following chronic blockade with scopolamine: a SPECT study. |
| Q48370189 | Divergent regulation of muscarinic binding sites and acetylcholinesterase in discrete regions of the developing human fetal brain |
| Q40875061 | Drug Therapy in the Elderly: The Clinical Pharmacology of Aging |
| Q35838504 | Effect of neocortical and hippocampal amyloid deposition upon galaninergic and cholinergic neurites in AβPPswe/PS1ΔE9 mice |
| Q36807678 | Effects of Ncl. Basalis Meynert volume on the Trail-Making-Test are restricted to the left hemisphere. |
| Q44345247 | Effects of the kappa-opioid dynorphin A(1-13) on learning and memory in mice |
| Q51986327 | Efficacy and safety of a loading-dose regimen versus a no-loading-dose regimen of metrifonate in the symptomatic treatment of Alzheimer's disease: a randomized, double-masked, placebo-controlled trial. Metrifonate Study Group. |
| Q28318950 | Evidence for a direct cholinergic involvement in the scopolamine-induced amnesia in monkeys: Effects of concurrent administration of physostigmine and methylphenidate with scopolamine |
| Q53195969 | Evidence for an increased rate of choline efflux across erythrocyte membranes in Alzheimer's disease. |
| Q39552901 | Experimental approaches to age-related cognitive impairments |
| Q74590828 | Frontotemporal dementia |
| Q39237724 | Functional Implications of Changes in the Senescent Brain: A Review |
| Q38661128 | Functional activation of Gαq coupled to 5-HT2A receptor and M1 muscarinic acetylcholine receptor in postmortem human cortical membranes |
| Q36713096 | Galantamine potentiates the neuroprotective effect of memantine against NMDA-induced excitotoxicity. |
| Q53196303 | Glucose metabolism and acetylcholine synthesis in relation to neuronal activity in Alzheimer's disease. |
| Q38036408 | Grafts, growth factors and grafts that make growth factors. |
| Q48118556 | Hidden-figures-test performance: Lasting effects of unilateral penetrating head injury and transient effects of bilateral cingulotomy |
| Q48744464 | High affinity uptake of GABA and glycine by rabbits with aluminum-induced neurofibrillary changes |
| Q90862831 | History and progress of hypotheses and clinical trials for Alzheimer's disease |
| Q72111862 | In vivo measurement of acetylcholinesterase activity in the brain with a radioactive acetylcholine analog |
| Q49108576 | In vivo quantification of cerebral muscarinic receptors in normal human aging using positron emission tomography and [11C]tropanyl benzilate |
| Q57317974 | Increased CSF HVA response to arecoline challenge in Alzheimer's disease |
| Q48826879 | Increased muscarinic receptor messenger RNA in Alzheimer's disease temporal cortex demonstrated by in situ hybridization histochemistry |
| Q50998089 | Induction of apoptotic change in the rat hippocampus caused by ferric nitrilotriacetate. |
| Q48250407 | Intravenous physostigmine treatment of Alzheimer's disease evaluated by psychometric testing, regional cerebral blood flow (rCBF) measurement, and EEG. |
| Q50583367 | Involutional dementias: new perspectives. |
| Q34177060 | Involvement of 5-HT(2A/2B/2C) receptors on memory formation: simple agonism, antagonism, or inverse agonism? |
| Q39275304 | Is the loss of cerebral cortical choline acetyl transferase activity in Alzheimer's disease due to degeneration of ascending cholinergic nerve cells |
| Q48703778 | Laminar alterations in gamma-aminobutyric acidA, muscarinic, and beta adrenoceptors and neuron degeneration in cingulate cortex in Alzheimer's disease |
| Q46305106 | Late life depression: undertreated? |
| Q48584488 | Memory function and brain biochemistry in normal aging and in senile dementia |
| Q42472368 | Metabolic alterations in the hypothalamus and basal forebrain in vascular dementia |
| Q48241160 | Muscarinic acetylcholine receptor status in Alzheimer's disease assessed using (R, R) 123I-QNB SPECT. |
| Q48105018 | Muscarinic cholinergic receptor subtypes in hippocampus in human cognitive disorders |
| Q44269773 | Muscarinic cholinoceptive neurons in the frontal cortex in Alzheimer's disease |
| Q72553350 | Muscarinic receptor compensation in hippocampus of Alzheimer patients |
| Q35818792 | Neocortical morphometry and cholinergic neurochemistry in Pick's disease |
| Q52103086 | Neurochemical activities in human temporal lobe related to aging and Alzheimer-type changes |
| Q40089993 | Neurotransmitter deficits in Alzheimer's disease: criteria for significance |
| Q40086658 | Neurotransmitter systems in aging and senile dementia |
| Q39262591 | Neurotransmitter-related enzymes in senile dementia of the alzheimer type |
| Q42588159 | Nicotinic receptor abnormalities in Alzheimer's and Parkinson's diseases |
| Q53307989 | Noradrenergic and cholinergic systems in senile dementia of Alzheimer type |
| Q40168435 | Nutrition and the neurosurgical patient |
| Q40126144 | Nutrition, Brain Function and Behavior |
| Q41611122 | Omental transposition to the brain for Alzheimer's disease |
| Q52216151 | Oral physostigmine and lecithin improve memory in Alzheimer disease |
| Q41431180 | Peripheral catecholamine enzyme function and cognitive impairment of elderly schizophrenics and controls |
| Q44127608 | Persistent calcium inward current in internally perfused snail neuron |
| Q48486634 | Pharmacokinetics, pharmacodynamics, and safety of metrifonate in patients with Alzheimer's disease |
| Q71002554 | Pharmacological aspects of gerontological brain research |
| Q48428624 | Pharmacological characterization of orally active cholinesterase inhibitory activity of Prunus persica L. Batsch in rats |
| Q48153927 | Physostigmine challenge before and after chronic cholinergic blockade in elderly volunteers. |
| Q45765813 | Pitfalls in membrane binding sites studies in post-mortem human brain |
| Q48912883 | Plaques, tangles and Alzheimer's disease |
| Q40163746 | Possible biochemical basis of memory disorder in Alzheimer disease |
| Q38069821 | Postsynaptic Receptors for Amyloid-β Oligomers as Mediators of Neuronal Damage in Alzheimer's Disease |
| Q48263628 | Presynaptic serotonergic dysfunction in patients with Alzheimer's disease |
| Q66698115 | Priorities in the N.H.S. |
| Q49011209 | Production of [14C]acetylcholine and [14C]carbon dioxide from [U-14C]glucose in tissue prisms from aging rat brain |
| Q41668347 | Protection by tris(hydroxymethyl)-aminomethane against behavioral and neurochemical effects of hypoxia |
| Q33638243 | Reappraising neurotransmitter-based strategies |
| Q46288568 | Recombinant human nerve growth factor infusions prevent cholinergic neuronal degeneration in the adult primate brain |
| Q53196325 | Reduced amounts of immunoreactive somatostatin in the temporal cortex in senile dementia of Alzheimer type |
| Q42488400 | Reduced choline acetyltransferase activity and muscarinic M1 receptor levels in aged Fisher 344 rat brains did not parallel their respective mRNA levels |
| Q48491658 | Reduced proteins in temporal cortex in Alzheimer's disease: an electrophoretic study |
| Q40083223 | Reduced somatostatin-like immunoreactivity in cerebral cortex from cases of Alzheimer disease and Alzheimer senile dementa |
| Q41962167 | Reduction in muscarinic receptor binding in limbic areas of Alzheimer brain |
| Q48103246 | Regional covariance of muscarinic acetylcholine receptors in Alzheimer's disease using (R, R) [(123)I]-QNB SPECT. |
| Q48244288 | Regional distribution of muscarinic acetylcholine receptor in normal and Alzheimer's-type dementia brains |
| Q37672243 | Regulation of mitochondrial pyruvate dehydrogenase activity by tau protein kinase I/glycogen synthase kinase 3beta in brain |
| Q40948694 | Research into the dementias |
| Q33940090 | Role of 5-HT(1A) and 5-HT(7) receptors in the facilitatory response induced by 8-OH-DPAT on learning consolidation |
| Q52196454 | SDZ ENA 713 facilitates central cholinergic function and ameliorates spatial memory impairment in rats. |
| Q38958570 | Safety and tolerability of metrifonate in patients with Alzheimer's disease: results of a maximum tolerated dose study |
| Q41441626 | Scopolamine reduces frontal cortex perfusion. |
| Q48300223 | Selective vulnerability of neurones in organic dementia |
| Q72540024 | Serratia pseudobacteremia |
| Q72565505 | Serum neuroleptic activity, prolactin, and tardive dyskinesia in schizophrenic outpatients |
| Q48793819 | Sex differences in age-related brain atrophy |
| Q48715478 | Somatostatin and dementia in Parkinson's disease |
| Q39775828 | Spontaneously hypertensive rats: further evaluation of age-related memory performance and cholinergic marker expression |
| Q51938231 | Substantia innominata: MR findings in Parkinson's disease. |
| Q33618671 | Tetrahydrobiopterin metabolism in senile dementia of Alzheimer type |
| Q47133877 | The Impact of Medication Anticholinergic Burden on Cognitive Performance in People With Schizophrenia |
| Q70132673 | The aging brain |
| Q34441061 | The cholinergic system in Alzheimer's disease |
| Q39554675 | The cortical dementias |
| Q39765984 | The current status of the cortical cholinergic system in Alzheimer's disease and Parkinson's disease |
| Q27687404 | The dendritic hypothesis for Alzheimer's disease pathophysiology |
| Q52091302 | The effects of thyrotropin-releasing hormone and scopolamine in Alzheimer's disease and normal volunteers. |
| Q48857951 | The failing brain |
| Q41491303 | The fimbria-fornix/cingular bundle pathways: a review of neurochemical and behavioural approaches using lesions and transplantation techniques |
| Q49071885 | The interaction of chronic alcohol consumption and aging on brain structure and function |
| Q40091112 | The neurochemistry of Alzheimer's disease and senile dementia |
| Q39483754 | The nucleus basalis of Meynert in neurological dementing disease: a review |
| Q42744385 | The psychiatrist's role in the care of the elderly. |
| Q57526641 | The treatment of Alzheimer's disease |
| Q40113445 | The use of cholinergic precursors in neuropsychiatric diseases |
| Q49070295 | The use of monoamine oxidase inhibitors in the treatment of elderly, depressed patients |
| Q35236387 | Therapeutic approaches to age-associated neurocognitive disorders |
| Q42513990 | Transplantation of basal forebrain cells of foetal rats into the subarachnoid space: improvement of disturbance of passive avoidance memory due to injury of nucleus basalis magnocellularis |
| Q66886617 | Trial of levodopa in senile dementia |
| Q41847403 | [14C]acetylcholine synthesis and [14C]carbon dioxide production from [U-14C]glucose by tissue prisms from human neocortex |
| Q52806808 | pH or hydrogen-ion concentration in statistics? |
Search more.